Aggressive PCa fails to express androgen receptor (AR), displays varying degrees of neuroendocrine transdifferentiation, possesses distinctive oncogenic and tumor suppressor gene amplification or loss of function mutations, activates the DNA damage response, and upregulates signaling pathways stimulating proliferation [7]. The gene discussed is AR; the disease is neoplasm.